Drug Interactions with Herbal Medicines

被引:0
|
作者
Shaojun Shi
Ulrich Klotz
机构
[1] Huazhong University of Science and Technology,Department of Pharmacy, Union Hospital, Tongji Medical College
[2] Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology,undefined
[3] University of Tuebingen,undefined
来源
Clinical Pharmacokinetics | 2012年 / 51卷
关键词
Berberine; Ginsenosides; Silymarin; Hypericin; Fexofenadine;
D O I
暂无
中图分类号
学科分类号
摘要
In recent years, the issue of herbal medicine-drug interactions has generated significant concern. Such interactions can increase the risk for an individual patient, especially with regard to drugs with a narrow therapeutic index (e.g. warfarin, ciclosporin and digoxin). The present article summarizes herbal medicine-drug interactions involving mainly inhibition or induction of cytochrome P450 enzymes and/or drug transporters. An increasing number of in vitro and animal studies, case reports and clinical trials evaluating such interactions have been reported, and the majority of the interactions may be difficult to predict. Potential pharmacodynamic and/or pharmacokinetic interactions of commonly used herbal medicines (black cohosh, garlic, Ginkgo, goldenseal, kava, milk thistle, Panax ginseng, Panax quinquefolius, saw palmetto and St John’s wort) with conventional drugs are presented, and sometimes the results are contradictory. Clinical implications of herbal medicine-drug interactions depend on a variety of factors, such as the co-administered drugs, the patient characteristics, the origin of the herbal medicines, the composition of their constituents and the applied dosage regimens. To optimize the use of herbal medicines, further controlled studies are urgently needed to explore their potential for interactions with conventional drugs and to delineate the underlying mechanisms.
引用
收藏
页码:77 / 104
页数:27
相关论文
共 50 条
  • [41] Interactions of herbal products with conventional medicines and potential impact on pregnancy
    Buehler, BA
    BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY, 2003, 68 (06) : 494 - 495
  • [42] Herbal medicines
    Pirmohamed, M
    POSTGRADUATE MEDICAL JOURNAL, 2003, 79 (935) : 489 - 489
  • [43] Potential Interactions between Herbal Medicines and Conventional Drug Therapies Used by Older Adults Attending a Memory Clinic
    Julie M. Dergal
    Jennifer L. Gold
    Dara A. Laxer
    Monica S. W. Lee
    Malcolm A. Binns
    Krista L. Lanctôt
    Morris Freedman
    Paula A. Rochon
    Drugs & Aging, 2002, 19 : 879 - 886
  • [44] Assessment of Undergraduate Nursing Students' Understanding of Herbal Medicines and Herb-Drug Interactions in Riyadh, Saudi Arabia
    Alharbi, Kholoud
    Bakarman, Safiya Salem
    Syed, Wajid
    Bashatah, Adel
    MEDICAL SCIENCE MONITOR, 2024, 30
  • [45] Potential of herb-drug / herb interactions between substrates and inhibitors of UGTs derived from herbal medicines
    Liu, Dan
    Zhang, Lin
    Duan, Lixin
    Wu, Jinjun
    Hu, Ming
    Liu, Zhongqiu
    Wang, Caiyan
    PHARMACOLOGICAL RESEARCH, 2019, 150
  • [46] Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic
    Dergal, JM
    Gold, JL
    Laxer, DA
    Lee, MSW
    Binns, MA
    Lanctôt, KL
    Freedman, M
    Rochon, PA
    DRUGS & AGING, 2002, 19 (11) : 879 - 886
  • [47] Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions (vol 5, 162, 2014)
    Mazzari, Andre L. D. A.
    Prieto, Jose M.
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [48] Herbal medicines
    Chattopadhyay, MK
    CURRENT SCIENCE, 1996, 71 (01): : 5 - 5
  • [49] Combating Drug Resistance in Colorectal Cancer Using Herbal Medicines
    Lee Ga-Young
    Lee Jin-Seok
    Son Chang-Gue
    Lee Nam-Hun
    Chinese Journal of Integrative Medicine, 2021, 27 (07) : 551 - 560
  • [50] Pharmacovigilance off the beaten track: Drug surveillance of herbal medicines
    Castot, A
    Djezzar, S
    Deleau, N
    Guillot, B
    Efthymiou, ML
    THERAPIE, 1997, 52 (02): : 97 - 103